Cancer stem cells in urologic cancers. (Q37629344)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897386%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

review article

1 reference

title

Cancer stem cells in urologic cancers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897386%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

main subject

neoplastic stem cells

1 reference

based on heuristic

inferred from title

author name string

Adee-Jonathan Davidson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897386%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Martin R Elmes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897386%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Damien Bolton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897386%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Ian D Davis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897386%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

7 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897386%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897386%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897386%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897386%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

585-590

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897386%20AND%20SRC:MED&resulttype=core&format=json

Hormone-refractory prostate cancer: what have we learned?

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Sunitinib therapy in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

The fuzzy math of solid tumor stem cells: a perspective.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

A self-renewal assay for cancer stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

A perivascular niche for brain tumor stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Prospective identification of tumorigenic breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

CD44: from adhesion molecules to signalling regulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Characterization of the Hoechst 33342 side population from normal and malignant human renal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

ALDH1 as a functional marker of cancer stem and progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Targeting cancer stem cells through L1CAM suppresses glioma growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

The expression of bcl-2 and bcl-6 protein in normal and malignant transitional epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

The urologic epithelial stem cell database (UESC) - a web tool for cell type-specific gene expression and immunohistochemistry images of the prostate and bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Patterns of splice variant CD44 expression by normal human urothelium in situ and in vitro and by bladder-carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

7 January 2021

Stem cells in the kidney

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Isolation of renal progenitor cells from adult human kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

CD133+ renal progenitor cells contribute to tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Identification of a tumor-initiating stem cell population in human renal carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

The path toward identifying prostatic stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

CD133, a novel marker for human prostatic epithelial stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Prospective identification of tumorigenic prostate cancer stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Expression profiling of CD133+ and CD133- epithelial cells from human prostate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Predicting the clinical course of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Aberrant expression and distribution of the OCT-4 transcription factor in seminomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

The stem cell identity of testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Novel germ cell markers characterize testicular seminoma and fetal testis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Germ cell lineage differentiation in non-seminomatous germ cell tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

The pluripotency homeobox gene NANOG is expressed in human germ cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Presumed pluripotency markers UTF-1 and REX-1 are expressed in human adult testes and germ cell neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

High-resolution comparative genomic hybridization detects extra chromosome arm 12p material in most cases of carcinoma in situ adjacent to overt germ cell tumors, but not before the invasive tumor development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Chromosomal imbalances associated with carcinoma in situ and associated testicular germ cell tumours of adolescents and adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

Primary cell cultures as models of prostate cancer development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.06.010

10.1016/J.UROLONC.2009.06.010

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897386%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference